论文部分内容阅读
目的:研究并分析产科弥散性血管内凝血患者的诱发因素与临床治疗效果,以不断提高此疾病的治愈率。方法:我院2009年4月1日-2013年4月1日期间共诊断出产科弥散性血管内凝血患者20例,上述患者分别运用不同的方式进行治疗:对患者的产科原发疾病进行积极治疗,去除导致患者弥散性血管内凝血的诱因;在患者高凝期积极给予肝素抗凝剂进行治疗,每次25-50mg,间歇给药,每日给药量为50-200mg之间;在患者消耗性低凝期给予其血浆和血小板等进行代替治疗,并适当运用小剂量肝素进行治疗;在患者纤溶期给予其适当的抗纤溶药物。结果:本组20例患者痊愈15例,好转4例,死亡1例,死于多脏器功能衰竭。结论:对产科弥散性血管内凝血患者应及时诊断、去除诱因,并在上述治疗的基础上运用肝素抗凝剂进行治疗,科学预防患者脏器衰竭,以最大限度的挽救患者生命。
Objective: To study and analyze the predisposing factors and clinical effects of obstetric disseminated intravascular coagulation in order to continuously improve the cure rate of this disease. Methods: 20 cases of obstetric disseminated intravascular coagulation were diagnosed in our hospital from April 1, 2009 to April 1, 2013. The above patients were treated with different methods respectively: the patients were active in the primary obstetric disease Treatment to remove the cause of disseminated intravascular coagulation in patients with incentives; in patients with hypercoagulable active treatment of heparin anticoagulants, each 25-50mg, intermittent administration, the daily dose of 50-200mg; between Consumption of patients with low coagulation given to their plasma and platelet replacement therapy, and appropriate use of low-dose heparin for treatment; in patients with fibrinolytic given appropriate anti-fibrinolytic drugs. Results: Twenty patients in this group were cured 15 cases, improved in 4 cases, 1 died, died of multiple organ failure. Conclusion: Obstetric disseminated intravascular coagulation patients should promptly diagnose and remove the causes, and in the above treatment based on the use of heparin anticoagulants for treatment, scientific prevention of patients with organ failure, in order to maximize the saving of patient’s life.